NASDAQ:RDNT RadNet (RDNT) Stock Forecast, Price & News $28.94 +0.01 (+0.03%) (As of 05/31/2023 ET) Add Compare Share Share Today's Range$28.20▼$29.2850-Day Range$23.14▼$28.9452-Week Range$12.03▼$29.47Volume417,757 shsAverage Volume251,260 shsMarket Capitalization$1.69 billionP/E RatioN/ADividend YieldN/APrice Target$30.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability RadNet MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside3.7% Upside$30.00 Price TargetShort InterestHealthy3.26% of Float Sold ShortDividend StrengthN/ASustainability-0.52Upright™ Environmental ScoreNews Sentiment0.96Based on 5 Articles This WeekInsider TradingSelling Shares$138,413 Sold Last QuarterProj. Earnings Growth7.14%From $0.28 to $0.30 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.04 out of 5 starsMedical Sector603rd out of 1,006 stocksMedical Laboratories Industry17th out of 24 stocks 1.5 Analyst's Opinion Consensus RatingRadNet has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $30.00, RadNet has a forecasted upside of 3.7% from its current price of $28.94.Amount of Analyst CoverageRadNet has only been the subject of 2 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.26% of the float of RadNet has been sold short.Short Interest Ratio / Days to CoverRadNet has a short interest ratio ("days to cover") of 5.7.Change versus previous monthShort interest in RadNet has recently decreased by 3.49%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldRadNet does not currently pay a dividend.Dividend GrowthRadNet does not have a long track record of dividend growth. Previous Next 4.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreRadNet has received a 72.34% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Mammography services ", "Nuclear medicine imaging services", and "MRI services" products. See details.Environmental SustainabilityThe Environmental Impact score for RadNet is -0.52. Previous Next 3.3 News and Social Media Coverage News SentimentRadNet has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for RadNet this week, compared to 2 articles on an average week.MarketBeat Follows1 people have added RadNet to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, RadNet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $138,413.00 in company stock.Percentage Held by InsidersOnly 5.10% of the stock of RadNet is held by insiders.Percentage Held by Institutions68.27% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for RadNet are expected to grow by 7.14% in the coming year, from $0.28 to $0.30 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of RadNet is -120.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of RadNet is -120.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRadNet has a P/B Ratio of 3.42. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About RadNet (NASDAQ:RDNT) StockRadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and reduce unnecessary invasive procedures. The firm offers magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures. RadNet was founded by Howard G. Berger in 1980 and is headquartered in Los Angeles, CA.Read More Receive RDNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter. Email Address RDNT Stock News HeadlinesMay 28, 2023 | americanbankingnews.comInsider Selling: RadNet, Inc. (NASDAQ:RDNT) Director Sells 4,884 Shares of StockMay 24, 2023 | finance.yahoo.comAre Investors Undervaluing RadNet, Inc. (NASDAQ:RDNT) By 42%?June 1, 2023 | Legacy Research (Affiliate) (Ad)“You need at least $100 of this asset – and it’s NOT gold” – Dr. Nomi Prin$100 is all you need… Former Goldman Sachs managing director Dr. Nomi Prins has identified an investment she’s calling ‘the world’s hardest asset’ – and she’s recommending it to friends, family, and followers.May 22, 2023 | americanbankingnews.comRadNet (NASDAQ:RDNT) Receives New Coverage from Analysts at StockNews.comMay 13, 2023 | seekingalpha.comRadNet, Inc. (RDNT) Q1 2023 Earnings Call TranscriptMay 12, 2023 | msn.comRaymond James Maintains Radnet (RDNT) Outperform RecommendationMay 11, 2023 | americanbankingnews.comRadNet (NASDAQ:RDNT) Trading Down 7% on Disappointing EarningsMay 10, 2023 | markets.businessinsider.comRaymond James Keeps Their Buy Rating on Radnet (RDNT)June 1, 2023 | Vantage Point (Ad)Stop Trading Like A TurtlePerforming at your best requires quick reaction and adaptability. While slow and steady progress works for some, having a tool that enables informed trading decisions is essential amid volatility. It's 2023. Why trade like a turtle when you could track down new opportunities like a cheetah? May 9, 2023 | markets.businessinsider.comRadNet earnings: here's what Wall Street expectsMay 8, 2023 | americanbankingnews.comRadNet (RDNT) to Release Quarterly Earnings on TuesdayMay 4, 2023 | finance.yahoo.comMaryland Governor Moore Signs RadNet-supported Legislation to Make Follow-up Diagnostic Imaging for Breast and Lung Cancers More AffordableMay 3, 2023 | finance.yahoo.comWith 69% ownership of the shares, RadNet, Inc. (NASDAQ:RDNT) is heavily dominated by institutional ownersMay 3, 2023 | americanbankingnews.comRadNet (NASDAQ:RDNT) Reaches New 52-Week High at $28.60May 1, 2023 | finance.yahoo.comRadNet’s Quantib B.V. Subsidiary Receives FDA Clearance for its Quantib Prostate™ 3.0 SoftwareApril 27, 2023 | finance.yahoo.comRadNet, Inc. Announces Date of its First Quarter 2023 Financial Results Conference CallApril 19, 2023 | seekingalpha.comRadNet: In For A Big FY 2023, Look For De Novo ContributionsApril 14, 2023 | msn.comChart of the Day: RadNet - Analysts look for 17%+ gainsApril 13, 2023 | finance.yahoo.comRadNet (NASDAQ:RDNT) shareholders notch a 33% CAGR over 3 years, yet earnings have been shrinkingApril 8, 2023 | americanbankingnews.comRadNet (NASDAQ:RDNT) Reaches New 1-Year High at $25.82April 3, 2023 | americanbankingnews.comCJS Securities Begins Coverage on RadNet (NASDAQ:RDNT)March 23, 2023 | finance.yahoo.comThere Are Reasons To Feel Uneasy About RadNet's (NASDAQ:RDNT) Returns On CapitalMarch 21, 2023 | finance.yahoo.comRadNet, Inc. to Present at the Sidoti & Company 2023 Virtual Spring Investor Conference on Wednesday, March 22ndMarch 20, 2023 | finance.yahoo.comWhy Fast-paced Mover RadNet (RDNT) Is a Great Choice for Value InvestorsMarch 13, 2023 | finance.yahoo.comRadNet, Inc. to Present at the Barclays Global Healthcare Conference on Thursday, March 16thMarch 9, 2023 | finance.yahoo.comAre Investors Undervaluing RadNet (RDNT) Right Now?March 6, 2023 | finance.yahoo.comRadNet, Inc. to Present at the 43rd Annual Cowen & Company Healthcare Conference on Tuesday, March 7thSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive RDNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter. Email Address RDNT Company Calendar Last Earnings5/09/2023Today6/01/2023Next Earnings (Estimated)8/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medical laboratories Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:RDNT CUSIPN/A CIK790526 Webwww.radnet.com Phone(310) 445-2800Fax310-445-2980Employees9,067Year Founded1980Price Target and Rating Average Stock Price Forecast$30.00 High Stock Price Forecast$30.00 Low Stock Price Forecast$30.00 Forecasted Upside/Downside+3.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.24) Trailing P/E RatioN/A Forward P/E Ratio103.36 P/E GrowthN/ANet Income$10.65 million Net Margins-0.90% Pretax Margin1.35% Return on Equity3.28% Return on Assets0.67% Debt Debt-to-Equity Ratio1.73 Current Ratio0.84 Quick Ratio0.84 Sales & Book Value Annual Sales$1.43 billion Price / Sales1.18 Cash Flow$3.54 per share Price / Cash Flow8.17 Book Value$8.45 per share Price / Book3.42Miscellaneous Outstanding Shares58,350,000Free Float55,370,000Market Cap$1.69 billion OptionableOptionable Beta1.64 Social Links Key ExecutivesHoward G. BergerChairman, Co-President & Chief Executive OfficerNorman R. HamesCo-President & COO-Western OperationsStephen M. ForthuberCo-President & COO-Eastern OperationsMark D. StolperChief Financial Officer & Executive Vice PresidentJohn V. CruesMedical Director & Vice PresidentKey CompetitorsVeracyteNASDAQ:VCYTFulgent GeneticsNASDAQ:FLGTViridian TherapeuticsNASDAQ:VRDNProgenityNASDAQ:PROGCastle BiosciencesNASDAQ:CSTLView All CompetitorsInsiders & InstitutionsChristine Nayoma GordonSold 4,884 sharesTotal: $138,412.56 ($28.34/share)Ameriprise Financial Inc.Sold 6,383 shares on 5/22/2023Ownership: 0.413%Putnam Investments LLCSold 1,163 shares on 5/22/2023Ownership: 0.343%JPMorgan Chase & Co.Bought 119,126 shares on 5/18/2023Ownership: 0.421%New York State Common Retirement FundSold 11,157 shares on 5/18/2023Ownership: 0.044%View All Insider TransactionsView All Institutional Transactions RDNT Stock - Frequently Asked Questions Should I buy or sell RadNet stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RDNT shares. View RDNT analyst ratings or view top-rated stocks. What is RadNet's stock price forecast for 2023? 2 brokerages have issued 1-year price targets for RadNet's stock. Their RDNT share price forecasts range from $30.00 to $30.00. On average, they expect the company's stock price to reach $30.00 in the next twelve months. This suggests a possible upside of 3.7% from the stock's current price. View analysts price targets for RDNT or view top-rated stocks among Wall Street analysts. How have RDNT shares performed in 2023? RadNet's stock was trading at $18.83 on January 1st, 2023. Since then, RDNT shares have increased by 53.7% and is now trading at $28.94. View the best growth stocks for 2023 here. When is RadNet's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023. View our RDNT earnings forecast. How were RadNet's earnings last quarter? RadNet, Inc. (NASDAQ:RDNT) announced its quarterly earnings data on Tuesday, May, 9th. The medical research company reported ($0.08) EPS for the quarter, missing analysts' consensus estimates of ($0.07) by $0.01. The medical research company had revenue of $390.60 million for the quarter, compared to analyst estimates of $371.34 million. RadNet had a negative net margin of 0.90% and a positive trailing twelve-month return on equity of 3.28%. RadNet's quarterly revenue was up 14.3% on a year-over-year basis. During the same period in the prior year, the company earned ($0.15) earnings per share. What ETFs hold RadNet's stock? ETFs with the largest weight of RadNet (NASDAQ:RDNT) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), iShares Micro-Cap ETF (IWC), iShares S&P Small-Cap 600 Value ETF (IJS), SPDR S&P 600 Small CapValue ETF (SLYV), Vanguard S&P Small-Cap 600 Value ETF (VIOV), iShares U.S. Healthcare Providers ETF (IHF) and Timothy Plan US Small Cap Core ETF (TPSC). What guidance has RadNet issued on next quarter's earnings? RadNet issued an update on its FY 2023 earnings guidance on Tuesday, May, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.55 billion-$1.60 billion, compared to the consensus revenue estimate of $1.56 billion. What is Howard G. Berger's approval rating as RadNet's CEO? 174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of RadNet own? Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA), Rigel Pharmaceuticals (RIGL), UnitedHealth Group (UNH), Pfizer (PFE) and AT&T (T). What is RadNet's stock symbol? RadNet trades on the NASDAQ under the ticker symbol "RDNT." Who are RadNet's major shareholders? RadNet's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (11.83%), Beck Mack & Oliver LLC (5.58%), Edmond DE Rothschild Holding S.A. (4.41%), State Street Corp (3.12%), Dimensional Fund Advisors LP (2.69%) and Global Alpha Capital Management Ltd. (2.67%). Insiders that own company stock include Christine Nayoma Gordon, David L Swartz, John V Crues, Lawrence L Levitt, Lawrence L Levitt, Michael N Murdock, Norman R Hames and Ruth Louisa Villigerwilson. View institutional ownership trends. How do I buy shares of RadNet? Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is RadNet's stock price today? One share of RDNT stock can currently be purchased for approximately $28.94. How much money does RadNet make? RadNet (NASDAQ:RDNT) has a market capitalization of $1.69 billion and generates $1.43 billion in revenue each year. The medical research company earns $10.65 million in net income (profit) each year or ($0.24) on an earnings per share basis. How many employees does RadNet have? The company employs 9,067 workers across the globe. How can I contact RadNet? RadNet's mailing address is 1510 COTNER AVE, LOS ANGELES CA, 90025. The official website for the company is www.radnet.com. The medical research company can be reached via phone at (310) 445-2800, via email at investorrelations@radnet.com, or via fax at 310-445-2980. This page (NASDAQ:RDNT) was last updated on 6/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.